Show Search Form
human indexable | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||
registered interest | |||||||||||||
answer date | |||||||||||||
date | |||||||||||||
date tabled | |||||||||||||
ddp created | |||||||||||||
answering body |
|
||||||||||||
question status | Tabled | ||||||||||||
answering dept id | 17 | ||||||||||||
answering dept short name | Health and Social Care | ||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||
ddp modified |
|
||||||||||||
hansard heading | Coronavirus: Screening | ||||||||||||
house id | 2 | ||||||||||||
identifier | HL5111 | ||||||||||||
legislature |
|
||||||||||||
parliament number | 58 | ||||||||||||
question first answered |
|
||||||||||||
question first ministerially corrected |
|
||||||||||||
question text | To ask Her Majesty's Government, following the introduction of updated COVID-19 test validation approval processes (CTDA), what guidance is available to testing manufacturers regarding submitting applications (1) for new tests and (2) for an updated approved product; and what is the expected timescale from application to decision for such applications. | ||||||||||||
session |
|
||||||||||||
session number | 2 | ||||||||||||
tabling member printed |
|
||||||||||||
title | House of Lords Tabled Parliamentary Question 2021/22 HL5111 | ||||||||||||
type |
|
||||||||||||
uin | HL5111 | ||||||||||||
version | 1 | ||||||||||||
written parliamentary question type | Ordinary | ||||||||||||
answer |
|
||||||||||||
creator |
|
||||||||||||
publisher | 25277 | ||||||||||||
tabling member |
|